HOME
Leading the way to a cure

SCIENTIFIC PUBLICATIONS BY ALR FUNDED RESEARCHERS

Glomerular Bullets in Lupus

Mohan, Chandra, MD

University of Texas Southwestern Medical Center at Dallas

Renal disease is a leading cause of death in lupus, and anti-glomerular and anti-DNA antibodies are largely responsible for the renal damage seen. Dr. Mohan and his group have verified that when anti-DNA/glomerular antibodies are administered to healthy mice, these antibodies target the renal glomeruli and inflict disease. 

With the Pilot grant, the researchers will take advantage of this unique specificity to target therapeutic agents to the kidneys in lupus. Specifically, they will adorn steroid-containing liposomes with antiglomerular antibodies and inject them into mice with lupus nephritis.  

What this means for people with lupus: By targeting the therapeutic agent to the glomeruli using these “glomerular bullets,” Dr. Mohan and his team hope to identify a treatment that provides a greater benefit than currently available treatments with fewer side effects. Once the treatment is shown effective in mice, it may move onto human clinical trials. 


1.5 million

people in the U.S. have Lupus.

172 million

dollars committed to lupus research by the Lupus Research Alliance.


We're walking across the United States to raise awareness and funds for lupus research.

 

Show your support by visiting the Lupus Research Alliance online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.

Powered by Blackbaud
nonprofit software